MedTrace Logo

The Effects of Polymyxin-B Protects on Sepsis Induced Kidney Dysfunction: a Randomized Clinical Trial

NCT00490477 · Status: COMPLETED · Phase: PHASE3 · Type: INTERVENTIONAL · Enrollment: 16

Last updated 2010-06-08

Study results available
· View outcomes & findings →

Summary

Aim of the study is to verify whether Polymyxin-B hemoperfusion protects from renal dysfunction in patients with severe sepsis from gram negative infection.

Conditions

  • Gram-Negative Bacterial Infections
  • Sepsis

Interventions

DEVICE

Polymyxin -B fiber hemoperfusion system

two hours treatment for two days

Sponsors & Collaborators

  • University of Turin, Italy

    lead OTHER

Principal Investigators

  • marco ranieri, MD · University of Turin, Department of Anesthesia and Intensive Care Medicine

  • marco ranieri, MD · University of Turin, Department of Anesthesia and Intensive Care Medicine

Study Design

Allocation
RANDOMIZED
Purpose
PREVENTION
Masking
NONE
Model
PARALLEL

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2006-05-31
Primary Completion
2007-07-31
Completion
2007-12-31

Countries

  • Italy

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT00490477 on ClinicalTrials.gov